Anti-Inflammatory Effects Inflammation is necessary for wound healing but must be carefully regulated
Your consultation ensures you understand what to expect, receive appropriate pre-care instructions, and have realistic expectations about both results and the healing process
Yen K, Wan J, Mehta HH et al (2018) Humanin prevents age-related cognitive decline in mice and is associated with improved cognitive age in humans
One option
Welche Rolle spielen Wachstumsfaktoren bei der Wirkung von BPC 157
Faster escalation (8-week to 2.4mg) Accelerated titration: Weeks 1-2: 0.6mg weekly Weeks 3-4: 1.2mg weekly Weeks 5-6: 1.8mg weekly Week 7+: 2.4mg weekly Who can attempt: No significant nausea on GLP-1s previously Generally strong GI tolerance Motivated for rapid weight loss Willing to accept higher side effect risk Can reduce dose if needed Expected experience: More pronounced nausea (weeks 3-5 especially) Faster adaptation curve Quicker weight loss onset Reaches maximum efficacy 4+ weeks sooner Success factors: Aggressive nausea management from start Ginger, B6, anti-nausea meds ready Small meal prep planned Ready to slow down if needed Higher maintenance doses (3.0-4.5mg) Rationale: Trials showed 3.0mg and 4.5mg produce slightly more weight loss Some individuals tolerate well Investigational approach 3.0mg weekly: ~11% average weight loss Moderate increase in side effects Reasonable middle ground Some find optimal here 4.5mg weekly: ~12% average weight loss (maximum) Significantly worse nausea/vomiting High dropout rate Not recommended routinely Only for exceptional tolerators Titration to higher doses: Reach 2.4mg first (standard titration) Stable at 2.4mg for 4-8 weeks Increase to 3.0mg if tolerating perfectly Consider 4.5mg only if 3.0mg easy Risk-benefit analysis: 3.0mg: May be worth it for some (1% extra loss) 4.5mg: Usually not worth it (2% extra loss, major side effects) Cost increases proportionally Individual decision Combination with other peptides for synergy Cagrilintide + Semaglutide (CagriSema): Most studied, proven synergy Both at 2.4mg weekly 15-25% total weight loss See detailed combination protocols below Cagrilintide + CJC-1295/Ipamorelin: Cagrilintide: 2.4mg weekly (fat loss) CJC-1295: 200-300mcg 5x weekly (muscle preservation) Ipamorelin: 200-300mcg 5x weekly (body composition) Preserves muscle during aggressive weight loss Better body composition outcomes Cagrilintide + BPC-157: Cagrilintide: 2.4mg weekly (weight loss) BPC-157: 250-500mcg twice daily (gut health) BPC-157 may help with GI side effects Supports gut during weight loss Complementary mechanisms See our peptide stacks guide , peptide stack calculator , CJC-1295 dosage calculator , Ipamorelin benefits , BPC-157 guide , and BPC-157 dosage calculator
